Bio Essence (BIOE) Capital Expenditures (2020 - 2022)

Bio Essence's Capital Expenditures history runs 3 years deep, the most recent figure standing at -$49851.0 for Q4 2022.

• In Q4 2022, Capital Expenditures fell 155.48% year-over-year to -$49851.0; the TTM figure through Dec 2023 stood at $92049.0 (down 8.92% YoY), while the FY2023 annual figure was $3614.0, down 3.42% from the prior year.
• Capital Expenditures was -$49851.0 for Q4 2022 at Bio Essence, down from $52053.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $89847.0 in Q4 2021 to a low of -$49851.0 in Q4 2022.
• Historically, Capital Expenditures has averaged $18206.6 across 3 years, with a median of $9537.0 in 2021.
• The sharpest annual moves came in 2021 and 2022: Capital Expenditures soared 1463.1% in 2021, then slumped 155.48% in 2022.
• A 3-year view of Capital Expenditures shows it stood at $5748.0 in 2020, then jumped by 1463.1% to $89847.0 in 2021, then plunged by 155.48% to -$49851.0 in 2022.
• The last three Capital Expenditures figures came in at -$49851.0 (Q4 2022), $52053.0 (Q3 2022), and $89847.0 (Q4 2021), per Business Quant data.